Toxicity of thiopurines in patients with inflammatory bowel disease: Frequency and risk factors

被引：0
|
作者：
Ben Mustapha, N. [1 ]
Labidi, A. [1 ]
Serghini, M. [1 ]
Fekih, M. [1 ]
Boubaker, J. [1 ]
Filali, A. [1 ]
机构：
[1] La Rabta Hosp, Gastroenterol A, Tunis, Tunisia
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60431-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P310
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [31] The Evolving Role of Thiopurines in Inflammatory Bowel Disease
    Saurabh Kapur
    Stephen B. Hanauer
    Current Treatment Options in Gastroenterology, 2019, 17 (4) : 435 - 448
  • [32] Thiopurines Prevent Advanced Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2011, 140 (05) : S42 - S43
  • [33] Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease
    Ranjan, M. K.
    Vuyyuru, S. K.
    Kante, B.
    Kumar, P.
    Mundhra, S. K.
    Golla, R.
    Sharma, R.
    Sahni, P.
    Das, P.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I330 - I331
  • [34] The Evolving Role of Thiopurines in Inflammatory Bowel Disease
    Saurabh Kapur
    Stephen B. Hanauer
    Current Treatment Options in Gastroenterology, 2019, 17 (3) : 420 - 433
  • [35] Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
    Mukesh Kumar Ranjan
    Sudheer Kumar Vuyyuru
    Bhaskar Kante
    Peeyush Kumar
    Sandeep K. Mundhra
    Rithvik Golla
    Raju Sharma
    Peush Sahni
    Prasenjit Das
    Govind Makharia
    Saurabh Kedia
    Vineet Ahuja
    International Journal of Colorectal Disease, 2022, 37 : 1817 - 1826
  • [36] Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines
    Dotan, Iris
    Werner, Lael
    Vigodman, Sharon
    Agarwal, Shradha
    Pfeffer, Jorge
    Horowitz, Noya
    Malter, Lisa
    Abreu, Maria
    Ullman, Thomas
    Guzner-Gur, Hanan
    Halpern, Zamir
    Mayer, Lloyd
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (02) : 261 - 268
  • [37] Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
    Ranjan, Mukesh Kumar
    Vuyyuru, Sudheer Kumar
    Kante, Bhaskar
    Kumar, Peeyush
    Mundhra, Sandeep K.
    Golla, Rithvik
    Sharma, Raju
    Sahni, Peush
    Das, Prasenjit
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (08) : 1817 - 1826
  • [38] Review article: thiopurines in inflammatory bowel disease
    Derijks, L. J. J.
    Gilissen, L. P. L.
    Hooymans, P. M.
    Hommes, D. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (05) : 715 - 729
  • [39] Safety of thiopurines in the treatment of inflammatory bowel disease
    de Jong, DJ
    Derijks, LJJ
    Naber, AHJ
    Hooymans, PM
    Mulder, CJJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 : 69 - 72
  • [40] Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
    van Schaik, Fiona D. M.
    van Oijen, Martijn G. H.
    Smeets, Hugo M.
    van der Heijden, Geert J. M. G.
    Siersema, Peter D.
    Oldenburg, Bas
    GUT, 2012, 61 (02) : 235 - 240
12345